$AGIO

$36.85 -$0.15 (0.41%) Close

$AGIO Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$AGIO Management Team

Mr. Christopher Taylor

Vice President - Investor Relations and Corporate Communications

Age -

Compensation -

Sex Male

Ms. Tsveta Milanova

Chief Commercial Officer

Age 48

Compensation $2.453M USD

Sex Female

Dr. Jacqualyn Fouse

Chairman of the Board

Age 63

Compensation $443.8K USD

Sex Female

Mr. Brian Goff

Chief Executive Officer

Director

Age 56

Compensation $6.776M USD

Sex Male

Ms. Cecilia Jones

Chief Financial Officer

Age 50

Compensation $2.419M USD

Sex Female

Mr. James Burns

Chief Legal Officer

Age 47

Compensation $2.433M USD

Sex Male

Dr. Sarah Gheuens

Chief Medical Officer

Head - Research and Development

Age 46

Compensation $2.544M USD

Sex Female

Mr. Krishnan Viswanadhan

Chief Corporate Development and Strategy Officer

Age 46

Compensation -

Sex Male

Name / Title	Age	Compensation	Sex
Mr. Christopher Taylor Vice President - Investor Relations and Corporate Communications	-	-	Male
Ms. Tsveta Milanova Chief Commercial Officer	48	$2.453M USD	Female
Dr. Jacqualyn Fouse Chairman of the Board	63	$443.8K USD	Female
Mr. Brian Goff Chief Executive Officer Director	56	$6.776M USD	Male
Ms. Cecilia Jones Chief Financial Officer	50	$2.419M USD	Female
Mr. James Burns Chief Legal Officer	47	$2.433M USD	Male
Dr. Sarah Gheuens Chief Medical Officer Head - Research and Development	46	$2.544M USD	Female
Mr. Krishnan Viswanadhan Chief Corporate Development and Strategy Officer	46	-	Male

Board of Directors

From the proxy statement filed Apr 24, 2026

Directors

serving now

Independent

Not stated

the proxy does not say

Average tenure

6.0 years

from year joined

CEO also chairs the board

Jacqualyn A. Fouse

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Rahul Ballal	48	2022 4 years	Not stated	audit committee science and technology committee	Enliven Therapeutics, Inc.	Not stated
Brian Goff CEO	57	2022 4 years	Not stated	None stated	Intellia Therapeutics, Inc.	Paid as CEO
Cynthia Smith	57	2022 4 years	Not stated	compensation & people committee · Chair	Akebia Therapeutics, Inc., Protara Therapeutics, Inc., Spero Therapeutics, Inc., Tvardi Therapeutics, Inc.	$467,157
Kaye Foster	66	2014 12 years	Not stated	compensation & people committee nominating and corporate governance committee · Chair	Prime Medicine, Inc.	$498,407
Maykin Ho	73	2015 11 years	Not stated	audit committee nominating and corporate governance committee	BioMarin Pharmaceutical Inc., Kyntra Bio, Inc., Neumora Therapeutics, Inc.	Not stated
Jeffrey Capello	61	2023 3 years	Not stated	audit committee · Chair	Neogen Corporation	$469,657
Catherine Owen Adams	55	2023 3 years	Not stated	compensation & people committee	None stated	$458,407
Jacqualyn A. Fouse Board chair	64	2017 9 years	Not stated	science and technology committee	Incyte Corporation, Madrigal Pharmaceuticals, Inc.	Not stated
David Scadden	73	2017 9 years	Not stated	nominating and corporate governance committee science and technology committee · Chair	Editas Medicine, Inc.	$469,657
Jay Backstrom	71	2025 1 year	Not stated	science and technology committee	None stated	$657,149

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 24, 2026 states there were none.

Read it in the proxy

Comments

Company Executives

$AGIO Management Team

Mr. Christopher Taylor

Ms. Tsveta Milanova

Dr. Jacqualyn Fouse

Mr. Brian Goff

Ms. Cecilia Jones

Mr. James Burns

Dr. Sarah Gheuens

Mr. Krishnan Viswanadhan

Board of Directors

Related-party transactions

No related-party transactions disclosed